Import duties on pharmaceutical manufacturing inputs such as APIs cost patients US$1.2bn in the US and US$1.1bn in the EU, find Philipp Lamprecht and Matthias Bauer in this new Geneva Network working paper.
Senior Economist, European Centre for International Political Economy, Brussels
His areas of research include international trade, the economics of digital markets and the digital economy, European Single Market integration, European fiscal affairs and capital market policy.
Matthias studied business administration at the University of Hull, UK, and economics at the Friedrich Schiller University Jena, Germany. He received his Ph.D. degree after joining the Bundesbank graduate programme on the ‘Foundations of Global Financial Markets and Financial Stability’.
Before joining ECIPE, Matthias was the Coordinator of International Political Economy at the international cooperation division of Konrad Adenauer Foundation, Berlin. Previously, Matthias held positions at DekaBank, UBS, Mercedes-Benz China, and worked as a start-up and business development consultant.
To ensure modern trade and investment can continue on non-discriminatory terms for everyone, the WTO should put Intellectual property first.